Litcius/Paper detail

Transfer RNA-Derived Small RNAs: Novel Regulators and Biomarkers of Cancers

Bi-Fei Fu, Chaoyang Xu

2022Frontiers in Oncology29 citationsDOIOpen Access PDF

Abstract

Transfer RNA-derived small RNAs (tsRNAs) are conventional non-coding RNAs (ncRNAs) with a length between18 and 40 nucleotides (nt) playing a crucial role in treating various human diseases including tumours. Nowadays, with the use of high-throughput sequencing technologies, it has been proven that certain tsRNAs are dysregulated in multiple tumour tissues as well as in the blood serum of cancer patients. Meanwhile, data retrieved from the literature show that tsRNAs are correlated with the regulation of the hallmarks of cancer, modification of tumour microenvironment, and modulation of drug resistance. On the other side, the emerging role of tsRNAs as biomarkers for cancer diagnosis and prognosis is promising. In this review, we focus on the specific characteristics and biological functions of tsRNAs with a focus on their impact on various tumours and discuss the possibility of tsRNAs as novel potential biomarkers for cancer diagnosis and prognosis.

Topics & Concepts

Computational biologyBiologyRNABiomarkermicroRNACancerCancer biomarkersCancer researchBioinformaticsGeneticsGeneRNA modifications and cancerCancer-related molecular mechanisms researchMicroRNA in disease regulation
Transfer RNA-Derived Small RNAs: Novel Regulators and Biomarkers of Cancers | Litcius